Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02962882 · ClinicalTrials.gov registry record · NA
Pressure Injury Prevention in the ICU With Multi-Layer Foam Dressings
A NA study of Pressure Incidence Prevention, sponsored by Molnlycke Health Care AB.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT02962882 is a NA study of Pressure Incidence Prevention that has completed, run by Molnlycke Health Care AB. The registered enrollment target is 50 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT02962882, a NA study of Pressure Incidence Prevention, has completed, sponsored by Molnlycke Health Care AB.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
A Multi-Centre, Open, Non-controlled, Clinical Investigation to Evaluate the User Friendliness and Wear Time of Multi-layer Foam Dressings With Safetac® for Pressure Injury Prevention in the Intensive Care Unit
Conditions Studied
Interventions
- DEVICE Mepilex Border
Study Locations (2)
South Carolina
- Anmed Health - Anderson
- Roper Hospital - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-09-09 |
| Est. Completion | 2017-05-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02962882
The ClinicalTrials.gov registry entry for NCT02962882 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pressure Incidence Prevention appearing as the primary indexed condition, and to 1 intervention - of which Mepilex Border is the first listed.
NCT02962882 reports 2 study locations spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT02962882 about?
NCT02962882 is a clinical study titled "Pressure Injury Prevention in the ICU With Multi-Layer Foam Dressings". A Multi-Centre, Open, Non-controlled, Clinical Investigation to Evaluate the User Friendliness and Wear Time of Multi-layer Foam Dressings With Safetac® for Pressure Injury Prevention in the Intensive Care Unit
What is the current status of trial NCT02962882?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-09-09. Estimated completion is 2017-05-04.
What conditions does trial NCT02962882 study?
This clinical trial studies the following conditions: Pressure Incidence Prevention.
What interventions are being tested in trial NCT02962882?
The interventions under investigation include: Mepilex Border (DEVICE).
Who is sponsoring clinical trial NCT02962882?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02962882 being conducted?
This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.